NCT05070247 2026-01-22
A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Phase 1/2 Terminated
Takeda
University of Chicago
Montefiore Medical Center
University of Arizona
University of Alabama at Birmingham
OHSU Knight Cancer Institute
University of Washington